Financial results - ANDOMED BIOFAM SRL

Financial Summary - Andomed Biofam Srl
Unique identification code: 35538488
Registration number: J2016000141043
Nace: 8621
Sales - Ron
127.089
Net Profit - Ron
64.859
Employees
3
Open Account
Company Andomed Biofam Srl with Fiscal Code 35538488 recorded a turnover of 2024 of 127.089, with a net profit of 64.859 and having an average number of employees of 3. The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Andomed Biofam Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 2.767 31.861 51.288 66.210 71.118 81.745 92.756 105.844 127.089
Total Income - EUR - 2.767 31.861 51.288 66.948 74.311 81.746 92.757 106.361 127.552
Total Expenses - EUR - 4.076 20.155 23.671 25.251 30.527 28.072 32.445 41.079 58.944
Gross Profit/Loss - EUR - -1.309 11.707 27.618 41.697 43.785 53.674 60.312 65.282 68.609
Net Profit/Loss - EUR - -1.337 11.388 27.105 41.027 43.124 53.069 59.403 64.293 64.859
Employees - 3 3 3 3 3 3 3 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 20.7%, from 105.844 euro in the year 2023, to 127.089 euro in 2024. The Net Profit increased by 925 euro, from 64.293 euro in 2023, to 64.859 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Andomed Biofam Srl

Rating financiar

Financial Rating -
ANDOMED BIOFAM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Andomed Biofam Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Andomed Biofam Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Andomed Biofam Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Andomed Biofam Srl - CUI 35538488

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 130 0 0 44 94 796 687 48.753 38.988
Current Assets - 1.171 11.297 39.529 42.952 47.945 54.559 62.364 55.219 59.944
Inventories - 0 0 0 0 0 0 0 0 0
Receivables - 66 127 702 503 215 438 44.276 47.310 48.774
Cash - 1.105 11.170 38.827 42.448 47.730 54.120 18.088 7.909 11.170
Shareholders Funds - -1.292 10.118 37.037 41.098 43.183 53.126 59.451 64.341 64.907
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 2.594 1.179 2.491 1.898 4.856 2.229 3.600 39.631 34.025
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 59.944 euro in 2024 which includes Inventories of 0 euro, Receivables of 48.774 euro and cash availability of 11.170 euro.
The company's Equity was valued at 64.907 euro, while total Liabilities amounted to 34.025 euro. Equity increased by 925 euro, from 64.341 euro in 2023, to 64.907 in 2024.

Risk Reports Prices

Reviews - Andomed Biofam Srl

Comments - Andomed Biofam Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.